SDGR

#2523
Schrodinger, Inc. Common Stock
12.38 USD
+3.95%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
12.34
12.44
Jahresspanne
10.95
27.63
Tagesänderung
+3.95%
Monatliche Änderung
-1.90%
6 month change
-40.62%
Jahresänderung
-51.14%
Vorheriger Schlusskurs
11.91
Eröffnung
12.34
Bid
Ask
Tief
12.34
High
12.44
Volumen
129
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik
Vierteljährlich Jährlich
  • Market Capitalization 913.95 M
  • Employee 850
  • Founded 1990
  • CEO Ramy Farid
  • Website www.schrodinger.com
  • Headquarter Delaware, United States
  • FIGI BBG000T88BN2
  • Industry Technology
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Kurs-Gewinn-Verhältnis
-12.68
Preis-Umsatz-Verhältnis
5.13

Schrodinger Inc

Schrödinger, Inc. is an international scientific software and biotechnology company that specializes in developing computational tools and software for drug discovery and materials science. Schrödinger's software is used by pharmaceutical companies, biotech, tech, chemicals, energy, aerospace firms, and academic researchers to simulate and model the behavior of molecules at the atomic level. This accelerates the design and develops new drugs and materials more efficiently, reducing the time and cost of bringing them to market. Schrödinger's software tools include molecular dynamics simulations, free energy calculations, quantum mechanics calculations, and virtual screening tools. The company also offers consulting services and collaborates with partners in the industry to advance the field of computational chemistry and drug discovery.

Nachrichten